News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioCurex Inc. (BOCX) Announces Commercial Launch of Its RECAF Blood Test to Detect Cancer in Dogs



9/30/2010 9:59:53 AM

RICHMOND, British Columbia, Sept. 30, 2010 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) announced the commercial launch of its RECAF blood test for cancer in dogs through its wholly owned subsidiary, OncoPet Diagnostics.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES